Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer.

Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer.

Item
http://www.wikidata.org/entity/Q35852412
The economic burden of head and neck cancer: a systematic literature review.Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial.Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment.Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature.Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review.Management options for established chemotherapy-induced peripheral neuropathy.Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy.The impending financial healthcare burden and ethical dilemma of systemic therapy in metastatic cancer.Budget impact of everolimus for the treatment of progressive, well-differentiated, non-functional neuroendocrine tumors of gastrointestinal or lung origin that are advanced or metastatic.Chemotherapy-induced peripheral neuropathy: A current review.Taxane-Induced Peripheral Neurotoxicity.Long-term peripheral neuropathy symptoms in breast cancer survivors.Lack of paclitaxel effects on intracranial self-stimulation in male and female rats: comparison to mechanical sensitivity.Validity and usefulness of a single-item measure of patient-reported bother from side effects of cancer therapy.A novel endpoint for the assessment of chemotherapy-induced peripheral neuropathy in rodents: biomechanical properties of peripheral nerve.Assessment of costs associated with adverse events in patients with cancer.
P2860

Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer.

Item
http://www.wikidata.org/entity/Q35852412
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Healthcare costs and workloss ...... and nonsmall cell lung cancer.
@ast
Healthcare costs and workloss ...... and nonsmall cell lung cancer.
@en
type
label
Healthcare costs and workloss ...... and nonsmall cell lung cancer.
@ast
Healthcare costs and workloss ...... and nonsmall cell lung cancer.
@en
prefLabel
Healthcare costs and workloss ...... and nonsmall cell lung cancer.
@ast
Healthcare costs and workloss ...... and nonsmall cell lung cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Healthcare costs and workloss ...... and nonsmall cell lung cancer.
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P921
P932